ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,706.01
      -0.13%
      US Tech 100
      19,295.60
      -0.20%
      Dow Jones
      41,985.94
      -0.09%
      Brent Oil
      73.77
      -0.74%
      Bitcoin
      62,759.29
      -0.30%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Repligen Corp (RGEN)

      7. Repligen Corp (RGEN) Financials

      Repligen Corp

      Repligen Corp (RGEN)

      NASDAQ
      145.78
      3.75
      (2.64%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      145.78
      0.00
      ( 0.00% )
      Pre Market: 9:22AM
      Delayed by 15 minutes

      Repligen Corp Financial Summary

      The current RGEN market cap is 8.16B. The company's latest EPS is USD 0.7424 and P/E is 196.36.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 159.17M172.46M155.05M151.35M154.07M
      Operating Income 19.4M1.78M-887k2.03M1.49M
      Net Income 20.06M18.17M-25.49M2.09M3.32M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 270.25M366.26M670.53M830.27M669.33M
      Operating Income 36.08M69.82M167.25M224.67M54.58M
      Net Income 21.41M59.93M128.29M185.96M41.58M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.55B2.51B2.82B2.85B2.86B
      Total Liabilities 578.08M525.57M853.21M878.67M875.56M
      Total Equity 1.97B1.99B1.97B1.97B1.99B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.4B1.9B2.36B2.52B2.82B
      Total Liabilities 340.35M373.74M608.29M613.96M853.21M
      Total Equity 1.06B1.53B1.75B1.91B1.97B

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 45.62M84.85M113.92M44.71M86.9M
      Investing 55.4M46.63M-123.28M-8.36M-15.76M
      Financing -18.39M-19.17M248.96M-8.97M-14.75M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 67.22M62.63M119.02M172.08M113.92M
      Investing -205.31M-201.39M-221.17M-233.24M-123.28M
      Financing 484.87M305.92M961k-13.34M248.96M

      Stats and Ratios

      Market Cap 8.16B
      Price to Earnings Ratio 196.36
      Price to Sales Ratio 12.2
      Price to Cash Ratio 10.87
      Price to Book Ratio 4.14
      Dividend Yield -

      Share Statistics

      Shares Outstanding 56.01M
      Average Volume (1 week) 703.5k
      Average Volume (1 Month) 862.46k
      52 Week Change -12.31%
      52 Week High 211.13
      52 Week Low 110.45
      Spread (Intraday) 2.43 (1.65%)

      Company Info

      Company Name Repligen Corp
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.repligen.com
      Industry biological pds,ex diagnstics (2836)

      Your Recent History

      NASDAQ
      RGEN
      Repligen
      Delayed Upgrade Clock